Showing results (271-280 of 299) with videos related to
Sort By:
Pageof 30
Annals of Surgical Oncology|April 16, 2025
Enhancing Recurrence-Free Survival Prediction in Hepatocellular Carcinoma: A Time-Updated Model Incorporating Tumor Burden and AFP DynamicsMiho Akabane, Jun Kawashima, Abdullah Altaf, et al.Annals of Surgical Oncology|May 20, 2023
Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic CholangiocarcinomaLaura Alaimo, Henrique A Lima, Zorays Moazzam, et al.BMC Cancer|July 25, 2020
A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01)Osamu Itano, Yusuke Takemura, Norihiro Kishida, et al.Scientific Reports|May 13, 2024
Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinomaRyosuke Kasuga, Nobuhito Taniki, Po-Sung Chu, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 24, 2024
Prognostic value of the advanced lung cancer inflammation index in intrahepatic cholangiocarcinomaGiovanni Catalano, Laura Alaimo, Odysseas P Chatzipanagiotou, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 18, 2023
Albumin-Bilirubin Grade and Tumor Burden Score Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma After Hepatic Resection: a Multi-Institutional AnalysisMuhammad Musaab Munir, Yutaka Endo, Henrique A Lima, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 9, 2023
The impact of tumor location on the value of lymphadenectomy for intrahepatic cholangiocarcinomaYutaka Endo, Zorays Moazzam, Henrique A Lima, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 17, 2022
Predictive risk-score model to select patients with intrahepatic cholangiocarcinoma for adjuvant chemotherapyYutaka Endo, Zorays Moazzam, Laura Alaimo, et al.Frontiers in Immunology|September 29, 2025
Continuation of atezolizumab plus bevacizumab beyond initial progressive disease: clinical benefits in patients with unresectable hepatocellular carcinoma - a multicenter cohort studyTakaya Tabuchi, Nobuhito Taniki, Keisuke Ojiro, et al.BMJ Open|May 31, 2019
Comparison of olanexidine versus povidone-iodine for preventing surgical site infection in gastrointestinal surgery: study protocol for a multicentre, single-blind, randomised controlled clinical trialMasashi Takeuchi, Hideaki Obara, Hirofumi Kawakubo, et al.Pageof 30